Ascelia Pharma: The lead SPARKLE studies provide the first monthly progress update
Research Note
2022-12-30
13:46
Ascelia announced that 65 patients has now completed the SPARKLE study. This suggests that Ascelia is on track to achieved 80 patients by March or even late February.
JU
Johan Unnerus
Disclosures and disclaimers